Central adjudication of serious adverse events did not affect trial's safety results: Data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial.

<h4>Background and purpose</h4>Central adjudication of serious adverse events (SAEs) can be undertaken in clinical trials, especially for open-label studies where outcome assessment may be at risk of bias. This study explored the effect of central adjudication of SAEs on the safety results of the Ef...

詳細記述

書誌詳細

主要な著者:	Peter J Godolphin, Alan A Montgomery, Lisa J Woodhouse, Daniel Bereczki, Eivind Berge, Rónán Collins, Exuperio Díez-Tejedor, John Gommans, Kennedy R Lees, Serefnur Ozturk, Stephen Phillips, Stuart Pocock, Kameshwar Prasad, Szabolcs Szatmari, Yongjun Wang, Philip M Bath, Nikola Sprigg, ENOS Investigators
フォーマット:	Artigo
言語:	Inglês
出版事項:	Public Library of Science (PLoS) 2018-01-01
シリーズ:	PLoS ONE
オンライン･アクセス:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0208142&type=printable
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!